Longitudinal clinical characteristics and neuropsychological tests of patients with T2DM and of HCs
Time | Patients | HC | t/χ2 | P value | |
Gender (male/female) | Baseline | 16/11 | 19/17 | 0.262 | 0.608 |
Age (years) | Baseline | 55.037±7.633 | 52.250±6.942 | 1.511 | 0.136 |
Education (years) | Baseline | 11.815±3.270 | 10.861±2.850 | 1.234 | 0.222 |
BMI (kg/m2) | Baseline | 25.950±2.093 | 24.584±3.064 | 1.994 | 0.051 |
Follow-up | 25.664±1.938 | 24.855±3.099 | 1.270 | 0.209 | |
BP (HBP/normal) | Baseline | 8/19 | 4/32 | 3.431 | 0.064 |
Follow-up | 17/10 | 14/22 | 3.578 | 0.059 | |
HbA1c (%) | Baseline | 8.715±2.244 | 5.572±0.324 | 6.824 | <0.001* |
Follow-up | 7.589±1.849 | 5.650±0.427 | 5.331 | <0.001* | |
HbA1c (mmol/mol) | Baseline | 70.407±24.943 | 37.472±3.558 | 6.809 | <0.001* |
Follow-up | 59.407±20.140 | 38.281±4.658 | 5.332 | <0.001* | |
FBG (mmol/L) | Baseline | 8.001±2.313 | 5.086±0.611 | 6.284 | <0.001* |
Follow-up | 9.158±3.813 | 6.218±0.996 | 3.833 | 0.001* | |
TC (mmol/L) | Baseline | 5.167±1.603 | 5.351±0.925 | −0.573 | 0.569 |
Follow-up | 5.550±1.567 | 5.555±1.132 | −0.014 | 0.989 | |
TG (mmol/L) | Baseline | 2.236±1.832 | 1.529±0.689 | 1.906 | 0.066 |
Follow-up | 2.093±1.574 | 1.703±0.881 | 1.199 | 0.235 | |
HDL (mmol/L) | Baseline | 1.060±0.226 | 1.237±0.254 | −2.864 | 0.006* |
Follow-up | 1.269±0.330 | 1.337±0.284 | 0.852 | 0.398 | |
LDL (mmol/L) | Baseline | 3.192±1.035 | 3.431±0.837 | −1.013 | 0.315 |
Follow-up | 3.674±1.090 | 3.647±0.866 | 0.108 | 0.914 | |
MMSE | Baseline | 29.222±1.013 | 29.500±0.941 | −1.122 | 0.266 |
Δr | 0.026±0.044 | 0.048±0.061 | 1.604 | 0.114 | |
AVLT short-term | Baseline | 47.333±8.062 | 49.743±9.915 | −1.027 | 0.308 |
Δr | −0.048±0.187 | −0.068±0.167 | 0.447 | 0.657 | |
AVLT long-term | Baseline | 10.615±2.714 | 11.265±2.711 | −0.919 | 0.362 |
Δr | −0.093±0.243 | −0.034±0.333 | −0.760 | 0.450 | |
DST forward | Baseline | 8.370±1.214 | 8.200±1.079 | 0.584 | 0.562 |
Δr | −0.033±0.137 | −0.002±0.126 | −0.899 | 0.372 | |
DST backward | Baseline | 5.482±1.221 | 5.194±1.261 | 0.906 | 0.368 |
Δr | −0.047±0.251 | 0.090±0.335 | −1.788 | 0.079 | |
SAS | Baseline | 32.593±6.154 | 31.250±5.022 | 0.953 | 0.344 |
Follow-up | 36.574±7.910 | 37.076±8.171 | 0.245 | 0.808 | |
SDS | Baseline | 33.482±6.880 | 31.028±4.878 | 1.657 | 0.103 |
Follow-up | 37.732±10.006 | 38.333±10.133 | 0.235 | 0.815 |
χ2 test for gender and BP (n). Two-sample t-test for normally distributed continuous data (mean±SD).
*Indicates a significant difference between groups (p<0.05).
AVLT, Auditory Verbal Learning Test; BMI, body mass index; BP, blood pressure; DST, digit span test; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; HBP, high blood pressure; HCs, healthy controls; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MMSE, Mini-Mental State Examination; Δr, 5-year change rate; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depressive Scale; TC, total cholesterol; T2DM, type 2 diabetes mellitus; TG, triglyceride.